Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

avatar
Arrayfunction Private ID: 74271604
Investing primarily in bio-tech and drug development; both big pharma for growth and start-ups for speculation
Follow
    Seems pretty fitting that only after having to switch to a  "securing profits"  mode to trade elsewhere that my returns start to beat the indices! 😇 I greatly appreciate all the education and tutelage gained from the Moomoo community members along the way! Jaka szkoda - that the platform's policies pushed me out and forced relocation. I choose to bookend the experience with the sentiment that if the work of fellow users helped to raise up a complete novic...
    Stepping away from Moomoo on a high note!
    Especially the new folks, I recommend taking a second to read-up on the limitations Moomoo creates deeming all users to have margin accounts (while obfuscating this fact).
    I learned this the hard way and don't want anyone else to fall victim!  It is not information you can find without digging. Especially since Moomoo has a cash account option for Papertrade! So it's not an infrastructure issue - it's an intentional choice. This lower...
    2
    I noticed I was replying a lot to comments on smaller bio-techs and figured a post might be more coherent and hopefully help some folks.
    Obligatory disclaimer! I have only been trading for a few months but have worked at a pre-clinical CRO for ~7 years so this is an industry post rather than financial.
    Small bio-tech companies are, by design, meant to die from Day 1. There are no long-term time horizons. It d...
    I am quite stumped about $GlaxoSmithKline(GSK.US)$ in the past few weeks. It has had fairly steady long-term growth in the past few years and there doesn't seem to be that much worrying news recently. Is it just going through an oscillation at the moment?
    I began investing in the stock market for the first time back in April of this year. At 32 years old, I had never given investing any serious thought prior to this year. My mind held onto the antiquated notion of, outside of my 401k, the stock market and investing was something only rich people did. So I have a lot of conceptual catching up to do! Definitely not something you master in three months 🙂 I am pretty satisfied with my overall P/L despite it being in t...
    My first 3 months in the markets!
    My first 3 months in the markets!
    My first 3 months in the markets!
    +5
    2
    $NLS Pharmaceutics(NLSP.US)$  Based off the trend markers, the stock doesn't seem to have been massively overbought. The fact that so much flowed out without completely tanking was more robust stock than I expected. It still seems to be in a period of overcorrection. Given the limited volatility in the past, the trend will eventually reverse course. Hard to say what the final numbers will look like since that mostly depends on how much emotiona...
    Will be interesting to see when the recovery will be
    3
    I have seen some confusion around the terms; hopefully this can help understand the investment implications.
    An IND submission is when a company has completed (at least the minimum) required animal toxicology and safety assessment [preclinical] studies and are seeking FDA approval to start safety assessment trials in humans [Phase I]. Approval is not dependent on whether they think the drug candidate is effective, only if the drug has been shown to have a low enough ris...
    Overview: FDA IND vs NDA
    Overview: FDA IND vs NDA
    My value strategy focuses on long positions by attempting to optimize for signal to noise ratio and identifying the types of response curves seen in both past and current data.
    The basic ideas stem from my experience with multivariate time series analysis from other disciplines. I apologize if I don't use the correct terminology. I may also have what seem like obvious omissions due to not knowing what the metrics for certain stats are called here, so I defini...
    Incorporating time series smoothing
    3